학술논문
Editorial commentary to "18F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases" by Grkovski and colleagues.
Document Type
Editorial
Source
Subject
*BRAIN metastasis
*STEREOTACTIC radiosurgery
*DIFFUSION magnetic resonance imaging
*POSITRON emission tomography
*SURGICAL excision
*
*
*
*
Language
ISSN
1619-7070
Abstract
Dear Editor, We read with great interest the paper of Grkovski et al. recently published in the I European Journal of Nuclear Medicine and Molecular Imaging i [[1]] investigating SP 18 sp F-fluorocholine ( SP 18 sp F-FCH) PET in patients with progressive brain metastases previously treated by stereotactic radiosurgery (SRS) and scheduled for surgical resection. The prospective study presented by Grkovski and colleagues is interesting as SP 18 sp F-FCH PET/CT has not yet been tested to differentiate response from progression of brain metastases treated by radiotherapy. [Extracted from the article]